Murat Ozbalak

5PUBLICATIONS
43CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 15, 2025
Outcomes of patients with Hodgkin lymphoma receiving Brentuximab Vedotin (BV) as maintenance therapy after ASCT according to previous exposure to BV. A retrospective analysis of the EBMT Lymphoma Working Party in collaboration with GELTAMO, FIL, LYSA, and Turkish Lymphoma Group.

Carmen Martínez, Irma Khvedelidze, Mathilde Fekom

|Oct 28, 2023
Sequencing novel agents in the treatment of classical Hodgkin lymphoma.

Burhan Ferhanoglu, Murat Ozbalak

|Jun 03, 2022
Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience

Murat Özbalak, Metban Güzel Mastanzade, Özden Özlük

|Sep 16, 2021
Raman tweezers as an alternative diagnostic tool for paroxysmal nocturnal hemoglobinuria.

Kaan Batu Soysal, Seyma Parlatan, Metban Mastanzade

|Jun 25, 2021
Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study.

Olga Meltem Akay, Murat Ozbalak, Mustafa Pehlivan

Pageof 1

Frequent Collaborators

3 joint publications

Burhan Ferhanoglu

2 joint publications

Tugrul Elverdi

2 joint publications

Ipek Yonal Hindilerden

2 joint publications

Meliha Nalçacı